Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Nanovehicles for co-delivery of anticancer agents — Mahdi Zeinali (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Nanovehicles for co-delivery of anticancer agents
Shared by
Michael R Hamblin
Nanovehicles for co-delivery of anticancer agents
Article
2020
en
Authors
+5 more
MZ
Mahdi Zeinali
SA
Soheil Abbaspour‐Ravasjani
MG
Marjan Ghorbani
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2020
Immunomodulation by targeted anticancer agents
Giulia Petroni
,
Aitziber Buqué
,
Laurence Zitvogel
,
Guido Guido Kroemer
,
Lorenzo Galluzzi
Article
2007
Evaluation of HIF-1 inhibitors as anticancer agents
Gregg L. Friedman
Article
2006
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre
,
Guido Guido Kroemer
,
Éric Raymond
Article
2019
Advances on Natural Polyphenols as Anticancer Agents for Skin Cancer
Soraya Sajadimajd
,
Roodabeh Bahramsoltani
,
Amin Iranpanah
,
Jayanta Kumar Patra
,
Gitishree Das
,
Sushanto Gouda
,
Roja Rahimi
,
Elnaz Rezaeiamiri
,
Hui Cao
,
Francesca Giampieri
,
Maurizio Battino
,
Rosa Tundis
,
María G. Campos
,
Mohammad Hosein Farzaei
,
Jianbo Xiao
Editorial Material
2014
Immunogenic cell death inducers as anticancer agents
Oliver Kepp
,
Laura Senovilla
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.